Keenova Announces Publication of XIAFLEX® (collagenase clostridium histolyticum) Manuscript in Translational Andrology and Urology

XIAFLEXPositive

AI Analysis

Summary

Keenova Therapeutics announced publication of a manuscript examining baseline penile pain as a potential factor influencing treatment outcomes in Peyronie's disease patients treated with XIAFLEX (collagenase clostridium histolyticum).

Importance:2/10

Sentiment:

0.30

manuscript publicationPeyronie's diseaseclinical researchXIAFLEX

Read the original article

Published by PR Newswire Pharma on August 3, 2026 11:30 AM

Read Original